Chemotherapy-induced peripheral neuropathy (CIPN) occurs in 30% to 60% of patients receiving chemotherapy, with limited options for treatment once symptoms develop. Evidence suggests that cryotherapy can reduce CIPN by inducing vasoconstriction and limiting drug exposure to peripheral nerves. In this session, we will discuss the development and implementation of an evidence-based cryotherapy intervention, outcomes demonstrating reduced CIPN incidence and severity, and lessons learned regarding patient adherence, staff training, and workflow integration. Participants will gain strategies to translate similar interventions into their own oncology practice settings.  

Learning Objectives: At the conclusion of this session, learners will be able to:   

• Describe the evidence surrounding the incidence and clinical impact of chemotherapy-induced peripheral neuropathy (CIPN) and the gap in effective preventive interventions  
• Explain the physiological mechanisms by which cryotherapy reduces the risk of CIPN in patients receiving chemotherapy 
• Discuss patient- and treatment-related factors identified in the implementation project that influence cryotherapy adherence and CIPN outcomes 
• Apply lessons learned from this project to enhance cryotherapy adherence, address barriers to cold tolerance, and integrate similar interventions into clinical workflows  

Contact Hours: 1

CRNI^® RUs: 2